Alpha 2.0
Login Register
» Articles » PMID: 39243150

Tailored Chemotherapy: Innovative Deep-learning Model Customizing Chemotherapy for High-grade Serous Ovarian Carcinoma

Overview
Journal Clin Transl Med
Publisher Wiley
Specialty General Medicine
Date 2024 Sep 7
PMID 39243150
Authors
Se Ik Kim
Sangick Park
Eunyong Ahn
Jeunhui Kim
HyunA Jo
Juwon Lee
Untack Cho
Maria Lee
Cheol Lee
Danny N Dhanasekaran
TaeJin Ahn
Yong Sang Song
Affiliations
Soon will be listed here.
Citing Articles

A quinoline-2-thione derivative as a novel chemotherapy drug candidate displays anti-tumor activity in vitro and in vivo.

Zhao J, Zhao J, Lin F, Xu L, Chen Z, Jiang Y BMC Cancer. 2024; 24(1):1272.

PMID: 39397012 PMC: 11472586. DOI: 10.1186/s12885-024-13042-7.

References
1.
Sun J, Bao S, Xu D, Zhang Y, Su J, Liu J . Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapy. Cell Death Dis. 2019; 10(9):661. PMC: 6737147. DOI: 10.1038/s41419-019-1874-9. View
2.
Dong A, Lu Y, Lu B . Genomic/Epigenomic Alterations in Ovarian Carcinoma: Translational Insight into Clinical Practice. J Cancer. 2016; 7(11):1441-51. PMC: 4964128. DOI: 10.7150/jca.15556. View
3.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View
4.
Zhang Y, Cao L, Nguyen D, Lu H . TP53 mutations in epithelial ovarian cancer. Transl Cancer Res. 2019; 5(6):650-663. PMC: 6320227. DOI: 10.21037/tcr.2016.08.40. View
5.
Hwangbo S, Kim S, Kim J, Eoh K, Lee C, Kim Y . Development of Machine Learning Models to Predict Platinum Sensitivity of High-Grade Serous Ovarian Carcinoma. Cancers (Basel). 2021; 13(8). PMC: 8070756. DOI: 10.3390/cancers13081875. View